| Predicate |
Object |
| contentType |
Journal Article|Review |
| issn |
1946-6242
1946-6234 |
| issueIdentifier |
127 |
| pageRange |
127rv2- |
| publicationName |
Science Translational Medicine |
| startingPage |
127rv2 |
| bibliographicCitation |
Stern HM. Improving treatment of HER2-positive cancers: opportunities and challenges. Sci Transl Med. 2012 Mar 28;4(127):127rv2. doi: 10.1126/scitranslmed.3001539. PMID: 22461643. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_240511214216263ef0ace93264af0b62 |
| date |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/22461643
https://doi.org/10.1126/scitranslmed.3001539 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1946-6242
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36963
https://portal.issn.org/resource/ISSN/1946-6234 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges |
| discusses |
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0001483 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D018719Q000037
http://id.nlm.nih.gov/mesh/D001943Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D019008Q000187
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D057170
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D018719Q000378 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |